Corcept Therapeutics | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Alaunos Therapeutics USD -7843000 633K 2023-12
ANI Pharmaceuticals USD -13762000 17.74M 2024-12
Ardelyx USD 4.68M 5.45M 2024-12
Aurora Cannabis CAD 32.07M 31.47M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
J&J USD 5.42B 1.86B 2024-12
Knight Therapeutics CAD -7144000 19.01M 2024-03
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Novartis USD 4.66B 269M 2024-12
Pacira USD 49.58M 8.89M 2024-09
Pfizer USD 4.44B 2.36B 2024-12
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
TG Therapeutics USD 25.45M 21.18M 2024-12



Corcept Therapeutics Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.